Activest Wealth Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$48.7K Sell
165
-55
-25% -$14.5K 0.01% 277
2026
Q2
$49.9K Buy
220
+55
+33% +$9.8K 0.01% 280
2026
Q1
$28.5K Sell
165
-55
-25% -$10.2K 0.01% 440
2025
Q4
$43.9K Buy
220
+218
+10,900% +$39.5K 0.01% 343
2025
Q3
$313 Hold
2
– – ﹤0.01% 995
2025
Q2
$303 Sell
2
-32
-94% -$4.27K ﹤0.01% 930
2025
Q1
$5.12K Buy
+34
New +$5.7K ﹤0.01% 499

Other funds holding CRL

Activest Wealth Management's CRL Position: Q3 2026 in Review

Activest Wealth Management reduced its Charles River Laboratories (CRL) stake by 25% in Q3 2026, selling an estimated $14.5K and leaving 165 shares worth $48.7K. The position accounts for 0.01% of the portfolio, ranked #277.

Activest Wealth Management first reported a position in CRL in Q1 2025 and has held it in 7 quarters since. The position peaked at $49.9K in Q2 2026. 644 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Activest Wealth Management held 165 shares of Charles River Laboratories worth $48.7K as of Q3 2026.
  • Activest Wealth Management sold 55 Charles River Laboratories shares in Q3 2026, an estimated $14.5K.
  • Charles River Laboratories made up 0.01% of Activest Wealth Management's portfolio in Q3 2026, its #277 holding.
  • Activest Wealth Management first reported a position in Charles River Laboratories in Q1 2025 and has held it in 7 quarters since.
  • Activest Wealth Management's Charles River Laboratories position peaked at $49.9K in Q2 2026.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.